Treating equine donor stem cells with a growth factor called TGF-β2 may allow them to avoid ‘tripping’ the immune response in recipients, according to new research from North Carolina State University. The work could simplify the stem cell treatment process for ligament and tendon injuries in horses, and may also have implications for human stem cell therapies.
Click here for original story, ‘Stealthy’ stem cells better for treating tendon injuries in horses
Source: Phys.org